Measurement of macrophage marker in hyperhaemolytic transfusion reaction: A case report

Transfusion Medicine

Volumn 22, Issue 2, 2012, Pages 137-141

  Win, N ^a   Lee, E ^a   Needs, M ^a   Chia, L W ^b   Stasi, R ^b  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

^b ST GEORGE S HOSPITAL   (United Kingdom)

Author keywords

Ferritin; Hyperhaemolytic transfusion reaction; Macrophage marker; Sickle cell disease

Indexed keywords

BILIRUBIN; C REACTIVE PROTEIN; ERYTHROCYTE ANTIBODY; FERRITIN; HEMOGLOBIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PETHIDINE; PREDNISOLONE; STEROID;

ABDOMINAL PAIN; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION REACTION; CASE REPORT; DISEASE ACTIVITY; DRUG MEGADOSE; ERYTHROCYTE; FERRITIN BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HUMAN CELL; HYPERHEMOLYTIC TRANSFUSION REACTION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MEASUREMENT; OXYGEN SATURATION; RETICULOCYTE COUNT; SICKLE CELL ANEMIA; SICKLE CELL CRISIS; TREATMENT RESPONSE;

ADULT; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; DUFFY BLOOD-GROUP SYSTEM; ERYTHROCYTE TRANSFUSION; FERRITINS; HEMOLYSIS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; ISOANTIBODIES; MACROPHAGE ACTIVATION; MACROPHAGES; MALE; RECEPTORS, CELL SURFACE;

EID: 84858793303     PISSN: 09587578     EISSN: 13653148     Source Type: Journal    
DOI: 10.1111/j.1365-3148.2011.01131.x     Document Type: Article

References (34)

1. Aygun, B., Padmanabhan, S., Paley, C. & Chandrasekaran, V. (2002) Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion, 42, 37-41.
2. Ballas, S.K. & Marcolina, M.J. (2006) Hyperhaemolysis during the evolution of uncomplicated acute painful episodes in patients with sickle cell anemia. Transfusion, 46, 105-110.
3. Belcher, J.D., Marker, P.H., Weber, J.P., Hebbel, R.P. & Vercellotti, G.M. (2000) Activated monocytes in sickle cell disease potential role in the activation of vascular endothelium an vaso-occlusion. Blood, 96, 2451-2459.
4. Boas, F.E., Forman, L. & Beutler, E. (1998) Phosphatidylserine exposure and red cell viability in red cell aging and in hemolytic anemia. Proceedings of the National Academy of Sciences of the United States of America, 95, 3077-3081.
5. Chadebech, P., Habibi, A., Nzouakou, R. et al. (2009) Delayed hemolytic transfusion reaction in sickle cell disease patients: evidence of an emerging syndrome with suicidal red blood cell death. Transfusion, 49, 1785-1792.
6. Daniels, G. (2002) Duffy blood group system. In: Human Blood Groups, 2nd edn, 329-331. Blackwell Science: ISBN 0-632-056460.
7. Darabi, K. & Dzik, S. (2005) Hyperhaemolysis syndrome in anaemia of chronic disease. Transfusion, 45, 1930-1933.
8. Eda, S. & Sherman, I.W. (2002) Cytoadherence of malaria-infected red blood cells involves exposure of phosphatidylserine. Cellular Physiology and Biochemistry, 12, 373-384.
9. Emmenenegger, U., Schaer, D.F., Larroche, C. & Neftel, K.A. (2005) Haemophagocytic syndromes in adults: current concepts and challenges ahead. Swiss Medical Weekly, 135, 299-314.
10. Fadok, V.A., Bratton, D.L., Rose, D.M., Pearson, A., Ezekewitz, R.A. & Henson, P.M. (2000) A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature, 405, 85-90.
11. Friedman, D.F., Kim, H.C. & Manno, C.S. (1993) Hyperhaemolysis associated with red cell transfusion in sickle cell disease. Transfusion, 33S, 148.
12. Garratty, G. (1997) Severe reactions associated with transfusion of patients with sickle cell disease. Transfusion, 37, 357-361.
13. Garratty, G. (2008) The James Blundell aware lecture 2007: do we really understand immune red cell destruction? Transfusion Medicine, 18, 321-334.
14. Hebbel, R.P. & Miller, V.B. (1984) Phagocytosis of sickle erythrocyte: Immunological and oxidative determinants of haemolytic anemia. Blood, 64, 733-741.
15. Ibarra, M.F., Klein-Gitelman, M., Morgan, E., Proytcheva, M., Sullivan, C., Morgan, G., Pachman, L.M. & O'Gorman, M.R. (2011) Serum neopterin levels as a diagnostic marker of hemophagocytic lymphohistiocytosis syndrome. Clinical and Vaccine Immunology, 18, 609-614.
16. King, K.E., Shirley, R.S., Lankiewicz, M.W., Young-Ramsaran, J. & Ness, P. (1997) Delayed haemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion, 37, 376-381.
17. Kristiansen, M., Graversen, J.H., Jacobsen, C., Sonne, O., Hoffman, H.J., Law, S.K. & Moestrup, S.K. (2001) Identification of the haemoglobin scavenger receptor. Nature, 409, 198-201.
18. Lambotte, O., Cacoub, P., Costedoat, N., Le Moel, G., Amoura, Z. & Piette, J.C. (2003) High ferritin and low glycosylated ferritin may also be a marker of excessive macrophage activation. Journal of Rheumatology, 30, 1027-1028.
19. Mendoza, E., Gutgsell, N., Temple, J.D. & Issitt, P. (1991) Monocyte phagocyte activity in sickle cell disease. Acta Haematologica, 85, 199-201.
20. Murr, C., Widner, B., Wirleitner, B. & Fuchs, D. (2002) Neopterin as a marker for immune system activation. Current Drug Metabolism, 3, 175-187.
21. Olteanu, H., Gerber, D. & Partridge, K. et al. (2005) Acute hemolytic transfusion reaction secondary to anti-Fy3. Immunohematology, 21, 48-52.
22. Petz, L.D., Calhoun, L., Shulman, I., Johnson, C. & Herron, R. (1997) The sickle cell haemolytic transfusion reaction syndrome. Transfusion, 37, 382-392.
23. Reyes, M.A. & Illoh, O.C. (2008) Hyperhemolytic transfusion reaction attributable to anti-Fy3 in a patient with sickle cell disease. Immunohematology, 24 45-51.
24. Rosse, W.F., Gallagher, D., Kenney, T.R., Castro, O., Dosik, H., Moohr, J., Wang, W. & Levy, P.S. (1990) Transfusion and alloimmunisation in sickle cell disease. The Cooperative Study of sickle cell disease. Blood, 76, 1431-1437.
25. Schaer, D.J., Schleiffenbaum, B., Kurrer, M. et al. (2005) Soluble hemoglobin-haptoglobin scavenger receptor CD163 as a lineage-specific marker in the reactive hemophagocytic syndrome. European Journal of Haematology, 74, 6-10.
26. Talano, J.M., Hillery, C.A., Gottschall, J.L., Baylerian, D.M. & Scott, J.P. (2003) Delayed haemolytic transfusion reaction/hyperhaemolysis syndrome in children with sickle cell disease. Pediatrics, 111, 661-665.
27. a preceding anti-Fy3 or -Fy5: a study of five cases [Abstract]. Transfusion, 25, 482.
28. Went, R., Wright, J., Webster, R. & Stamps, R. (2009) Anti-Fy3 in sickle cell disease: a difficult transfusion problem. British Journal of Haematology, 144, 621-622.
29. Win, N. (2009) Hyperhemolysis syndrome in sickle cell disease. Expert Review of Hematology, 2, 111-115.
30. Win, N., Doughty, H., Telfer, P., Wild, B. & Pearson, T. (2001) Haemolytic transfusion reaction in sickle cell disease. Transfusion, 41, 323-328.
31. Win, N., Tullie, Y., Needs, M., Chen, F.E. & Okpala, I. (2004) Use of intravenous immunoglobulin and intravenous methylprednisolone in hyperhaemolysis syndrome in sickle cell disease. Haematology, 9, 433-436.
32. Win, N., New, H., Lee, E. & de la Fuente, J. (2008) Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review. Transfusion, 48, 1231-1238.
33. Win, N., Sinha, S., Lee, E. & Mills, W. (2010) Treatment with intravenous imunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Transfusion Medicine Reviews, 24, 64-67.
34. Yuan, X.M., Li, W., Baird, S.K., Carlsson, M. & Melefors, O. (2004) Secretion of ferritin by iron-laden macrophages and influence of lipoproteins. Free Radical Research, 38, 1133-1142.